OECD Home › Directorate for Science, Technology and Industry › Publications & Documents
Publications & Documents
OECD economic globalisation indicators help identify the economic activities of member countries under foreign control, and more particularly the contribution of multinational enterprises to growth, employment, productivity, labour compensation, R&D, technology diffusion and int trade.
English, , 171kb
This Policy Brief describes some of the many channels of communication that are open for productive dialogue between the OECD and civil society.
English, , 175kb
The "Anti-Spam Regulation" paper has been prepared with the objective of aiding the development and review of anti-spam legislation strategies and arrangements in OECD member countries and non-member economies.
This book presents case studies on innovation policy governance in Australia, Austria, Belgium (Flanders), Finland, Greece, Ireland, Japan, Korea, Netherlands, New Zealand, Norway and Sweden. It provides fresh insight into how governments are striving to make innovation policy more coherent.
In order to foster innovation in their countries, governments first need to be able to measure it. But what means do they have at their disposal? The Oslo Manual provides them with the essential methodological guidelines.
English, , 176kb
Scoreboard 2005 Executive Summary Greece
While many countries have invested in the production of health technology assessment, evidence about its use in decision making is limited. This report analyses the barriers to, and facilitators of, evidence-based decision making in OECD health-care systems.
The number of broadband subscriptions throughout the OECD continued to increase in the first half of 2005 from 119 million to 137 million. Broadband penetration in the OECD grew by 15% in the first half of the year to 11.8 subscribers per 100 inhabitants. As penetration grows, broadband providers in the OECD increasingly are offering voice and video services over this platform.
This workshop brought together a wide range of stakeholders, including officials of regulatory agencies, representatives of relevant regional or international organizations, researchers, patients’ organizations and representative from industry.